No abstract available
MeSH terms
-
Animals
-
Antidepressive Agents, Second-Generation* / adverse effects
-
Antidepressive Agents, Second-Generation* / pharmacology
-
Antidepressive Agents, Second-Generation* / therapeutic use
-
Cognition Disorders / drug therapy
-
Dopamine D2 Receptor Antagonists
-
Double-Blind Method
-
Drug Discovery
-
Drug-Related Side Effects and Adverse Reactions
-
Humans
-
Piperazines* / adverse effects
-
Piperazines* / pharmacology
-
Piperazines* / therapeutic use
-
Piperidines* / adverse effects
-
Piperidines* / pharmacology
-
Piperidines* / therapeutic use
-
Randomized Controlled Trials as Topic
-
Schizophrenia / drug therapy*
-
Serotonin 5-HT2 Receptor Antagonists
-
Treatment Outcome
Substances
-
Antidepressive Agents, Second-Generation
-
Dopamine D2 Receptor Antagonists
-
Piperazines
-
Piperidines
-
Serotonin 5-HT2 Receptor Antagonists
-
blonanserin